Stockrabit · Analysts
Questions across 2 calls

Yogesh Soni

InCred

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-Nov25.pdf · 2025-10-31
Yes. Thanks for the opportunity. First question is on the Tier-2, 3 cities. If you could let me know how has been the growth in the first half? And secondly, if you could discuss about how the competitive intensity has been in these markets? And how are we strategizing our further growth?
If one wants to understand whether the presence of online players or other hospital diagnostic players has improved in these markets, can you help us understand on this?

Sun Pharmaceutical Industries Limited